Monitor for Form 144 filings or changes in trading plans; current sales are small relative to company size and likely routine, but continued selling could signal reduced confidence.
Price Chart
Executive Summary
Multiple NovoCure executives, including CEO Leonard Frank X and CMO Weinberg Uri, conducted open-market share sales totaling $441,770 over the past seven days, concurrent with routine stock grants and tax-related share surrenders. The selling activity is modest in dollar value and appears consistent with pre-arranged trading plans or diversification, rather than a coordinated negative signal.
Key Financial Metrics
Key Facts
- CEO Leonard Frank X sold $230,585 worth of shares in two transactions (7,232 shares at $13.49 and 9,734 shares at $13.66).
- CMO Weinberg Uri sold $146,863 in shares (3,272 at $13.33 and 7,461 at $13.84).
- CHRO Puri Michal Nath sold $34,325 in shares and was granted 40,100 shares (non-cash).
- COO Paravasthu Mukund sold $26,752 in shares.
- Former CEO Cordova Ashley had two tax withholding events totaling $191,633 (13,951 shares).
- Executive Chairman Doyle received a non-cash grant of 200,000 shares.
- Total open-market sales by insiders: $441,770 over 7 days.
- Total value of non-cash transactions (grants, tax withholding): $423,272.
Financial Impact
$441,770 in open-market sales over 7 days (~0.03% of $1.5B market cap)
Risk Factors
- Perception of insider selling may weigh on sentiment if misinterpreted.
- Concentration of sales among top executives (CEO, CMO) could raise questions if volume increases.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (16 trades, 7d window) | cluster-NVCR-1772746315399 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 8-K | $15.63 $16.38 | ▲ +4.80% | ▲ +5.13% | $14.94 (−4.41%) |
Sep 1, 2026 4w ago | 8-K | $17.38 $15.63 | ▼ −10.07% | ▼ −10.15% | $14.94 (−14.04%) |
Jul 23, 2026 10w ago | 8-K | $19.99 $15.23 | ▼ −23.81% | ▼ −24.29% | $14.94 (−25.26%) |
Jun 30, 2026 13w ago | 8-K | $15.15 $17.32 | ▲ +14.32% | ▲ +13.72% | $14.94 (−1.39%) |
Jun 18, 2026 15w ago | 8-K | $14.28 $15.05 | ▼ −5.39% | ▼ −7.06% | $14.94 (−4.62%) |
Jun 5, 2026 17w ago | 8-K | $16.85 $17.60 | ▲ +4.45% | ▲ +2.34% | $14.94 (−11.34%) |
Jun 3, 2026 17w ago | Insider Cluster | $17.99 $17.71 | ▼ −1.56% | ▲ +1.00% | $14.94 (−16.95%) |
Jun 3, 2026 17w ago | Insider Cluster | $17.99 $17.71 | ▼ −1.56% | ▲ +1.00% | $14.94 (−16.95%) |
Apr 20, 2026 23w ago | DEFA14A | $12.23 $12.12 | ▼ −0.90% | ▼ −1.98% | $14.94 (+22.16%) |
Feb 27, 2026 31w ago | Insider Cluster | $13.67 $13.04 | ▼ −4.61% | ▼ −2.63% | $14.94 (+9.29%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access